155 related articles for article (PubMed ID: 23378853)
1. A survey of quality control practices for high dose rate (HDR) and pulsed dose rate (PDR) brachytherapy in the United Kingdom.
Palmer AL; Bidmead M; Nisbet A
J Contemp Brachytherapy; 2012 Dec; 4(4):232-40. PubMed ID: 23378853
[TBL] [Abstract][Full Text] [Related]
2. Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments.
Visser AG; van den Aardweg GJ; Levendag PC
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):497-505. PubMed ID: 8567354
[TBL] [Abstract][Full Text] [Related]
3. A survey of the practice and management of radiotherapy linear accelerator quality control in the UK.
Palmer A; Kearton J; Hayman O
Br J Radiol; 2012 Nov; 85(1019):e1067-73. PubMed ID: 22674707
[TBL] [Abstract][Full Text] [Related]
4. GEC-ESTRO ACROP recommendations on calibration and traceability of HE HDR-PDR photon-emitting brachytherapy sources at the hospital level.
Perez-Calatayud J; Ballester F; Carlsson Tedgren Å; DeWerd LA; Papagiannis P; Rivard MJ; Siebert FA; Vijande J
Radiother Oncol; 2022 Nov; 176():108-117. PubMed ID: 36167195
[TBL] [Abstract][Full Text] [Related]
5. Development of a TLD mailed system for remote dosimetry audit for (192)Ir HDR and PDR sources.
Roué A; Venselaar JL; Ferreira IH; Bridier A; Van Dam J
Radiother Oncol; 2007 Apr; 83(1):86-93. PubMed ID: 17368842
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
Pop LA; Millar WT; Visser AG; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
[TBL] [Abstract][Full Text] [Related]
7. A high-Z inorganic scintillator-based detector for time-resolved in vivo dosimetry during brachytherapy.
Jørgensen EB; Johansen JG; Overgaard J; Piché-Meunier D; Tho D; Rosales HML; Tanderup K; Beaulieu L; Kertzscher G; Beddar S
Med Phys; 2021 Nov; 48(11):7382-7398. PubMed ID: 34586641
[TBL] [Abstract][Full Text] [Related]
8. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
9. Brachytherapy boost in anal canal cancer - A GEC ESTRO PDR task force meta-analysis.
Annede P; Ferre M; Kirisits C; Pieters BR; Schmid M; Strnad V; Westerveld H; Chargari C
Clin Transl Radiat Oncol; 2023 Mar; 39():100589. PubMed ID: 36785565
[TBL] [Abstract][Full Text] [Related]
10. A multicentre audit of HDR/PDR brachytherapy absolute dosimetry in association with the INTERLACE trial (NCT015662405).
Díez P; Aird EGA; Sander T; Gouldstone CA; Sharpe PHG; Lee CD; Lowe G; Thomas RAS; Simnor T; Bownes P; Bidmead M; Gandon L; Eaton D; Palmer AL
Phys Med Biol; 2017 Nov; 62(23):8832-8849. PubMed ID: 28984277
[TBL] [Abstract][Full Text] [Related]
11. Verification of high dose rate brachytherapy dose distributions with EBT3 Gafchromic film quality control techniques.
Palmer AL; Nisbet A; Bradley D
Phys Med Biol; 2013 Feb; 58(3):497-511. PubMed ID: 23306148
[TBL] [Abstract][Full Text] [Related]
12. Biological effect of pulsed dose rate brachytherapy with stepping sources if short half-times of repair are present in tissues.
Fowler JF; Van Limbergen EF
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):877-83. PubMed ID: 9128965
[TBL] [Abstract][Full Text] [Related]
13. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy.
Pötter R; Van Limbergen E; Gerstner N; Wambersie A
Radiother Oncol; 2001 Jan; 58(1):11-8. PubMed ID: 11165676
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract][Full Text] [Related]
15. Determination of air-kerma strength for the 192Ir GammaMedplus iX pulsed-dose-rate brachytherapy source.
Riley AD; Pike TL; Micka JA; Fulkerson RK; DeWerd LA
Med Phys; 2013 Jul; 40(7):071732. PubMed ID: 23822436
[TBL] [Abstract][Full Text] [Related]
16. The IPEM code of practice for determination of the reference air kerma rate for HDR (192)Ir brachytherapy sources based on the NPL air kerma standard.
Bidmead AM; Sander T; Locks SM; Lee CD; Aird EG; Nutbrown RF; Flynn A;
Phys Med Biol; 2010 Jun; 55(11):3145-59. PubMed ID: 20479510
[TBL] [Abstract][Full Text] [Related]
17. Monte Carlo study of the dose rate distributions for the Ir2.A85-2 and Ir2.A85-1 Ir-192 afterloading sources.
Granero D; Pérez-Calatayud J; Ballester F
Med Phys; 2008 Apr; 35(4):1280-7. PubMed ID: 18491521
[TBL] [Abstract][Full Text] [Related]
18. The feasibility study and characterization of a two-dimensional diode array in "magic phantom" for high dose rate brachytherapy quality assurance.
Espinoza A; Beeksma B; Petasecca M; Fuduli I; Porumb C; Cutajar D; Corde S; Jackson M; Lerch ML; Rosenfeld AB
Med Phys; 2013 Nov; 40(11):111702. PubMed ID: 24320410
[TBL] [Abstract][Full Text] [Related]
19. Quality control of brachytherapy equipment in the Netherlands and Belgium: current practice and minimum requirements.
Elfrink RJ; Kolkman-Deurloo IK; van Kleffens HJ; Rijnders A; Schaeken B; Aalbers TH; Dries WJ; Venselaar JL
Radiother Oncol; 2002 Jan; 62(1):95-102. PubMed ID: 11830317
[TBL] [Abstract][Full Text] [Related]
20. A review of the clinical experience in pulsed dose rate brachytherapy.
Balgobind BV; Koedooder K; Ordoñez Zúñiga D; Dávila Fajardo R; Rasch CR; Pieters BR
Br J Radiol; 2015; 88(1055):20150310. PubMed ID: 26290399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
